|
PI3King the right partner: unique interactions and signaling by p110ß
|
|
|
|
|
|
|
|
|
Hashem A. Dbouk
|
|
UT Southwestern Medical Center
|
6001 Forest Park Rd, ND7.202, Department of Pharmacology, Dallas, TX 75390-0001
|
hashem.dbouk@utsouthwestern.edu
|
|
|
|
|
|
|
|
Phosphoinositide 3-kinases (PI3Ks) are central regulators of cellular responses to extracellular stimuli, and are involved in growth, proliferation, migration, and metabolism. The Class I PI3Ks are activated by Receptor Tyrosine Kinases (RTKs) or G Protein-Coupled Receptors (GPCRs), and their signaling is commonly deregulated in disease conditions. Among the class I PI3Ks, the p110β isoform is unique in being activated by both RTKs and GPCRs, and its ability to bind Rho-GTPases and Rab5. Recent studies have characterized these p110β interacting partners, defining the binding mechanisms and regulation, and thus provide insight into the function of this kinase in physiology and disease. This review summarizes the developments in p110β research, focusing on the interacting partners and their role in p110β-mediated signaling.
|
|
|
|
|
|
|
|